...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Zenith Capital Corp. to Present on the Emerging Growth Conference on September 25, 2024

"Don't worry - DM stated Zenith shareholders would be receiving a dividend  payout this coming February - possibly sooner - he just needs a little cash and a couple of months to finalize the deal."

 

Chicagoest , any sarcasm to the the statement above ......we have heard from DM for over 5 years of a pending BP deal is imminently coming  needing more money now might mean a deal is not coming soon , I wait with baited breath for this to come true ....

Share
New Message
Please login to post a reply